Tumor Activity Articles & Analysis
35 articles found
Glycoprotein 1b on platelet surfaces assists tissue regeneration and injury repair by attaching to von Willebrand factor (vWF) and collagen from damaged blood vessels and when activated P-selectin from platelets becomes externalized it binds to PSGL-1 or CD44 on tumor cells thereby forming a defensive wall against tumor cells. ...
Anti-Tumor APIs: Pioneering Cancer Treatment Anti-tumor Active Pharmaceutical Ingredients (APIs) are vital in today's medical landscape, addressing one of the most pressing health challenges: cancer. These APIs form the foundation of various therapeutic strategies aimed at inhibiting or destroying tumor cells in the human body. ...
For instance, sphingolipids in exosomes are implicated in cancer progression by promoting exosome-mediated signaling that enhances tumor cell proliferation and immune evasion. Researchers have found that alterations in exosomal lipid profiles can be a hallmark of disease. In cancer, for example, exosomes derived from tumor cells exhibit changes in lipid ...
The platelet membranes are already bionic coatings that allow nanoparticles to bypass macrophage detection, catch on-target tumour cells and target inflammation sites, studies show recently. Tumor Cell Membrane in Bionic Nanomedicine Tumor cell membrane is produced after normal cells mutate. Recent studies have shown that tumor cells are ideal ...
The reactivity of disulfide bonds can be adjusted by steric hindrance: α-methyl substitution significantly affects the reduction rate and resistance to thiol-disulfide bond exchange. For example, the best anti-tumor activity of SPDB-DM4 was obtained by substituting the linker of SAR-3419 with geminal dimethyl. ...
Antibody-PROTAC conjugates combine the catalytic properties of PROTAC with the tissue specificity of ADC, thereby overcoming the traditional limitations of targeting degraders and ADCs, and have great potential in targeting new targets.ADC with NIR-PIT Drug as PayloadNear-infrared photoimmunotherapy (NIR-PIT) drugs typically consist of tumor-specific monoclonal antibodies that ...
RTKs are abnormally highly expressed on the surface of tumor cells, leading to malignant proliferation of tumor cells, and are therefore also important targets for tumor treatment. Single-target monoclonal antibodies against RTKs have been widely used in tumor treatment. However, tumor cells can ...
Beyond its immune-modulating functions, adenosine plays a role in adapting to hypoxic conditions and exhibits pro-angiogenic potential, further influencing the tumor microenvironment. CD73 and Adenosine Receptor Activity Promotes Immunosuppression Ecto-5′-nucleotidase (NT5E), commonly referred to as CD73, emerges as a central player in generating ...
In addition, Trop-2 is highly expressed in tumors and is associated with poor tumor prognosis. These characteristics all indicate that Trop-2 will become a good target for tumor treatment. ...
In vivo experiments showed that both GlueBody and GlueTAC treatment significantly inhibited tumor growth, with tumors treated with GlueTAC having a lower average weight compared to those treated with GlueBody. ...
In particular, linker design plays a key role in regulating ADC stability in systemic circulation and payload release efficiency in tumors, thereby affecting ADC pharmacokinetics (PK), efficacy, and toxicity profiles. ...
About Tumor Suppressor Genes A tumor suppressor gene, also known as anti-onco gene, is an essential component of the body's defense against cancer. ...
The Potential Risks of Host Cell Residual DNA: Host cell lines used in the production of biological products may harbor genes associated with tumors or viruses, presenting potential risks. For instance, rcDNA may carry the HIV virus or the Ras oncogene. The insertion of LINE-1 sequences, found in mammalian cell genomes, into chromosomes as retrotransposons can impact the ...
IL-17E (IL-25) IL-17E induces keratinocyte proliferation and can activate innate immune cells. In psoriasis, IL-17E is strongly expressed by keratinocytes and activates specific subtypes of macrophages (M2 or tissue macrophages). ...
High internalization is not necessarily beneficial to the treatment of solid tumors, because the rapid degradation of ADCs limits their ability to penetrate tumor masses. ...
Researcher Insco said that we found that CDK13 protein can play the role of tumor suppressor in melanoma, and its mutation or deletion can lead to tumor occurrence. ...
Specific targeting: The reported targeting strategies such as antibody-PROTAC conjugates can effectively improve the recognition of PROTAC molecules on tumors; PROTACs are activated by light, folic acid or reactive oxygen species in tumors through modification groups, which is also an effective way to reduce the potential toxicity of systemic ...
ADC drugs combine the high specificity of monoclonal antibody drugs with the high activity of small molecule cytotoxic drugs to improve the targeting of tumor drugs and reduce toxic side effects. ...
So far, studies have found that it has anti-metastasis and anticancer activities, antioxidant, free radical scavenging, hypoglycemic, hypolipidemic and other pharmacological activities, and a large number of experimental results show that its biological activities are better than curcumin, such as antioxidant chloroquine-induced kidney damage, ...
Summary Inflammation is a hallmark of the tumor microenvironment and an area of active investigation. To better understand how tumor inflammation differs from general inflammation, such as in gum disease, Drs. ...